Dr Shezad Malik Law Firm has offices based in Fort Worth and Dallas and represents people who have suffered catastrophic and serious personal injuries including wrongful death, caused by the negligence or recklessness of others. We specialize in Personal Injury trial litigation and focus our energy and efforts on those we represent.

Articles Tagged with Male Breast Growth

Risperdal lawsuit settlementsIf you file a Risperdal lawsuit, there is guarantee that you will win a trial verdict or obtain a settlement. But based on previous cases, it appears that the makers of Risperdal may be motivated to settle claims in order to avoid revealing information that may lead to more lawsuits or avoid trial verdicts.

Aron Banks was the first person to take his Risperdal personal injury claim to trail against the drug manufacturer. Banks was prescribed Risperdal when he was nine years old even though the drug wasn’t approved for use by children at the time. He experienced rapid weight gain, suffered injury to his endocrine system and experienced psychological trauma. He also developed breasts large enough to require surgery to remove them, a condition known as Gynecomastia.

In September 2012, the makers of Risperdal decided agreed to settle Banks case under the condition that neither Banks nor his attorney would reveal the amount. But his attorney did tell the media that he believed “the possibility of more evidence of off-label marketing and improper conduct by Johnson & Johnson had something to do with the settlement.”

Multiple lawsuits have been filed in the United States against the makers of Risperdal for failing to warn patients that it may cause male breast growth, a condition known as Gynecomastia.

Risperdal Male Breast Growth Lawsuit

Risperdal lawsuits increase in U.S.

Risperdal was approved for sale in the United States in 1993 by the Food and Drug Administration (FDA). It commonly used to treat irritability in people with autism, schizophrenia, and bipolar disorder.

Johnson & Johnson, (J&J) the world’s largest pharmaceutical and medical device maker recently received a one, two punch over its antipsychotic blockbuster drug, Risperdal.

Dallas Defective Medical Device attorneyThe drug manufacturer lost the first trial in state court in Philadelphia over allegations that Risperdal causes gynecomastia or abnormal breast growth in boys and young men exposed to the popular antipsychotic drug.

The jury slapped Johnson & Johnson to pony up $2.5 million in compensatory damages to a young Alabama man blamed the company for promoting the “off label” use of Risperdal, which in turn resulted in gynecomastia.

Currently underway in the State Court of Common Pleas in Philadelphia, there is a trial over the side effects of Risperdal, a popular antipsychotic medication. According to riveting court testimony, Johnson & Johnson (J&J), knew as early as 2001 that the medication caused boys to grow breasts.

Dallas Defective Medical Device attorneyThis testimony was provided by David Kessler, the former head of the U.S. Food and Drug Administration, in the first case over the antipsychotic medication to be decided by a jury in state court in Philadelphia.

J&J, no stranger to governmental fines, has paid more than $2 billion to resolve a criminal probe over its drug Risperdal.

Contact Information